How much input should patients have in medical decisions?

In the last decade, the clinician-patient relationship has become more of a partnership. There is growing interest in shared decision-making (SDM) in which the clinician and patient go through all phases of the decision-making process together, share treatment preferences, and reach an agreement on treatment choice. At the World Congress on Psychosomatic Medicine which opened today in Torino, Tom Sensky, Professor of Psychiatry at the Imperial College in London, raised some very controversial issues as to the participation of patients in medical decision.Data on randomised controlled trials (RCTs) comparing SDM interventions with non-SDM interventions were discussed. Five RCTs showed no difference between SDM and control, one RCT showed no short-term effects but showed positive longer-term effects, and five RCTs reported a positive effect of SDM on outcome measures. The two studies included of people with mental healthcare problems reported a positive effect of SDM.

Despite the considerable interest in applying SDM clinically, little research regarding its effectiveness has been done to date. It has been argued that SDM is particularly suitable for long-term decisions, especially in the context of a chronic illness, and when the intervention contains more than one session. Data show that under such circumstances, SDM can be an effective method of reaching a treatment agreement.

Evidence for the effectiveness of SDM in the context of other types of decisions, or in general, is still inconclusive. Future studies of SDM should probably focus on long-term decisions.
<b><font color=”#663366″>Source:</font></b> Psychotherapy and Psychosomatics Joosten, E.A.G.; DeFuentes-Merillas, L.; de Weert, G.H; Sensky, T; van der Staak, C.P.F; de Jong, C.A.J. Systematic Review of the Effects of Shared Decision-Making on Patient Satisfaction, Treatment Adherence and Health Status. Psychother Psychosom 2008;77:219-226.